Rubinstein et al., employing an innovative genetic model with pancreatic Klotho knockdown and a Kras mutation, demonstrated that the lack of KL accelerates the onset of pancreatic ductal adenocarcinoma and shortens survival in mice. The gene discussed is KL; the disease is pancreatic ductal adenocarcinoma.